Smith+Nephew
Edit

Smith+Nephew

http://www.arthrocare.com/
Last activity: 03.02.2014
Active
Categories: BusinessCareDesignHardwareHealthTechLivingMedTechProductSupplyTechnology
Smith+Nephew is a leading portfolio medical technology company using technology to take the limits off living.

Please note: not all products referred to may be approved for use or available in all markets.

◊ Trademark of Smith+Nephew
Likes
16.59K
Followers
7.41K
Mentions
6
Location: United Kingdom, England, Holywell
Employees: 10001+
Phone: +44 1923 477100
Founded date: 1856

Investors 1

Mentions in press and media 6

DateTitleDescription
03.02.2014Smith & Nephew Buys Austin-based ArthroCare for $1.7 BillionSmith & Nephew announced Monday a deal to buy ArthroCare Corp. of Austin for $1.7 billion. The London-based company plans to pay $48.25 per share in cash for the the medical device company. “This is a compelling opportunity to add Arthr...
09.01.2014ArthroCare Corp. Pays $30 Million Securities Fraud FineArthroCare Corp., a medical device maker in Austin, has agreed to pay a $30 million fine to settle securities fraud charges. The settlement resolves “charges that senior executives at the company engaged in a securities fraud scheme that re...
04.07.2013Austin-based ArthroCare Corp. Buys ENTrigue Surgical for $45 MillionFred Dinger has done it again. The San Antonio-based biotechnology entrepreneur sold his startup ENTrigue Surgical for $45 million to ArthroCare Corp. of Austin. Dinger previously sold OsteoBiologics for $72 million to Smith & Nephew En...
18.06.2012How do Wall Street analysts expect the Supreme Court to rule on Obamacare?People across the healthcare spectrum are waiting with baited breath to hear the U.S. Supreme Court’s verdict on President Barack Obama’s landmark healthcare reform law. Healthcare analysts at Minneapolis investment bank Piper Jaffray in Mi...
08.09.2011ArthroCare gets $8M to settle shareholder suit, denies wrongdoingArthroCare Corp. (NSDQ:ATRC) settled a shareholders’ lawsuit by agreeing to an $8 million payment from its insurers, more than a quarter of which will go to the plaintiffs’ lawyers, according to court documents. The Austin, Texas-based surg...
-How do Wall Street analysts expect the Supreme Court to rule on Obamacare?People across the healthcare spectrum are waiting with baited breath to hear the U.S. Supreme Court’s verdict on President Barack Obama’s landmark healthcare reform law. Healthcare analysts at Minneapolis investment bank Piper Jaffray in Mi...

Reviews 0

Sign up to leave a review

Sign up Log In